Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, southern Italy): Results of a pilot vaccination project

Research in Virology

Volumn 149, Issue 5, 1998, Pages 263-270

  Da Villa, G ^a   Piccinino, F ^a   Scolastico, C ^a   Fusco, M ^a   Piccinino, R ^a   Sepe, A ^a  

^a Ital Inst for Prev of Liver Dis   (Italy)

Author keywords

Epidemiology; HBV; Italy; Survey; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

CONFERENCE PAPER; DISEASE ASSOCIATION; ENDEMIC DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; INFECTION RISK; ITALY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREVALENCE; PRIORITY JOURNAL; VACCINATION;

EID: 0032158341     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(99)89004-9     Document Type: Conference Paper

References (12)

1. Blumberg, B.S. (1997), The current state of the prevention of HBV infection, the carrier state and hepatocellular carcinoma, Res. Viro., 148, 92-94.
2. Chang, M.H., Chen, C.J., Lai, M.S., Hsu, H.M., Wu, T.C., Kong, M.S., Liang, D.C., Shau, W.Y. & Chen, D.S., for the Taiwan Childhood Hepatoma Study Group (1997), Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children, N. Engl. J Med., 336, 1855-1859.
3. Chen, D.S., Hsu, M., Chang, M.H., Sung, J.L. & Hepatitis Control Committee (1996), Hepatitis B vaccines: status report on long-term efficacy, Proc. IX Triennal International Symposium on Viral Hepatitis and liver Disease, 21-25 April 1996, Rome Italy, p. 635.
4. Dardanoni, L., Mele, A. & Polizzi, M.C. (1988), Epidemiology of Hepatitis B in Italy. Annali dell'Istituto Superiore di Sanità, 24, 235-243.
5. Da Villa, G., Piazza, M., Iorio, R. et al. (1992), A pilot model of mass vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas. J. Med., Virol., 36, 276-278.
6. Da Villa, G., Picciotto, L., Elia, S., Peluso, F., Montanaro, F. & Maisto, T. (1995), Hepatitis B vaccination: universal vaccination of new-born babies and at 12 years of age versus high risk groups. A comparison in the field. Vaccine, 13, 1240-1243.
7. Da Villa, G., Peluso, F., Picciotto, L., Bencivenga, M., Elia, S. & Pelliccia, M.G. (1996), Persistence of anti-HBS in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years. Vaccine, 14, 1503-1505.
8. Lee, M.S. (1995), A cohort study on the casual association between hepatitis B virus infection and hepatocellular carcinoma with reference to the protective effect of vaccination against hepatitis B (Thesis). Seoul, Korea, Postgraduate School, Seoul National University.
9. Mastio, M.P., Palomba, A., Garau, M.G., Loi, I., Liguori, M. & Crociani, C. (1996), Hepatitis B virus infection: effect of vaccinal prophylaxis in children. Proc. IX Triennal International Symposium on Viral Hepatitis and liver Disease, April 1996, Rome, Italy (abstract C254).
10. McMahon, B.J., Mandsager, R., Wainwright, K., Wainwright, R., Williams, J. & Singleton, R. (1996), The Alaska native hepatitis B control program, Proc IX Triennal International Symposium on Viral Hepatitis and Liver Disease, 21-25 April 1996, Rome, Italy, pp. 702-704.
11. Viviani S., Jack, A.D., Maine, N., Montesano, R., Hall, A.J. & Mendi, M. (1996), The Gambia hepatitis intervention study. Proc. IX Triennal International Symposium on Viral Hepatitis and Liver Disease, April 1996, Rome, Italy (abstract C264).
12. Xu, Z.Y., Cao, H.L., Liu, C.B., Wang, S.S., Van, T.Q., Zhao, S.J. & Wu, W.S. (1996), Control of hepatitis B in China, Proceedings of the IX Triennial International Symposium on Viral Hepatitis and Liver Disease, 21-25 April, 1996, Rome Italy, pp. 689-690.